The process of ligand binding leading to receptor activation is an ord
ered and sequential one. High-affinity binding of GM-CSF, interleukin
3 (IL-3), and IL-5 to their receptors induces a number of key events a
t the cell surface and within the cytoplasm that are necessary for rec
eptor activation. These include receptor oligomerization, activation o
f tyrosine kinase activity, phosphorylation of the receptor, and the r
ecruitment of SH2 (src-homology) and PTB (phosphotyrosine binding) dom
ain proteins to the receptor. Such a sequence of events represents a r
ecurrent theme among cytokine, growth factor, and hormone receptors; h
owever, a number of very recent and interesting findings have identifi
ed unique features in this receptor system in terms of: A) how GM-CSF/
IL-3/IL-5 bind, oligomerize, and activate their cognate receptors; B)
how multiple biological responses such as proliferation, survival, and
differentiation can be transduced from activated GM-CSF, IL-3, or IL-
5 receptors, and C) how the presence of novel phosphotyrosine-independ
ent signaling motifs within a specific cytoplasmic domain of pc may be
important for mediating survival and differentiation by these cytokin
es, This review does not attempt to be all-encompassing but rather to
focus on the most recent and significant discoveries that distinguish
the GM-CSF/IL-3/IL-5 receptor subfamily from other cytokine receptors.